Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -94,743 | -39,506 | -132,617 | -93,226 | -57,621 |
| Depreciation Amortization | 539 | 227 | 564 | 349 | 155 |
| Accounts receivable | -7,487 | -3,963 | -6,951 | -8,705 | -1,335 |
| Accounts payable and accrued liabilities | -3,245 | 2,621 | 18,646 | 7,285 | 7,330 |
| Other Working Capital | -10,446 | -1,773 | 16,364 | 7,591 | 8,700 |
| Other Operating Activity | 26,703 | 4,231 | -2,817 | 8,041 | -1,828 |
| Operating Cash Flow | $-88,678 | $-38,163 | $-106,812 | $-78,667 | $-44,599 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,093 | -262 | -217 | -66 | -46 |
| Purchase Sale Intangibles | -763 | -404 | -21,105 | -20,749 | -435 |
| Other Investing Activity | -784 | -404 | -21,281 | -20,760 | -446 |
| Investing Cash Flow | $-1,876 | $-666 | $-21,498 | $-20,827 | $-492 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 200,000 | N/A | 75,000 | 75,000 | 75,000 |
| Debt Repayment | -81,661 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 100 | 100 | 91,574 | 91,144 | 1,129 |
| Other Financing Activity | -6,652 | 0 | -3,787 | -3,787 | -3,787 |
| Financing Cash Flow | $111,787 | $100 | $162,787 | $162,357 | $72,342 |
| Beginning Cash Position | 161,613 | 161,613 | 127,136 | 127,136 | 127,136 |
| End Cash Position | 182,846 | 122,884 | 161,613 | 189,999 | 154,387 |
| Net Cash Flow | $21,233 | $-38,729 | $34,478 | $62,864 | $27,251 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88,678 | -38,163 | -106,812 | -78,667 | -44,599 |
| Capital Expenditure | -1,093 | -262 | -217 | -66 | -46 |
| Free Cash Flow | -89,770 | -38,426 | -107,029 | -78,733 | -44,645 |